tradingkey.logo

BioNexus Gene Lab Corp

BGLC
2.110USD
+0.120+6.03%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
3.79MMarktkapitalisierung
VerlustKGV TTM

BioNexus Gene Lab Corp

2.110
+0.120+6.03%

mehr Informationen über BioNexus Gene Lab Corp Unternehmen

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

BioNexus Gene Lab Corp Informationen

BörsenkürzelBGLC
Name des UnternehmensBioNexus Gene Lab Corp
IPO-datumMar 11, 2020
CEOTan (Lee Su-Leng)
Anzahl der mitarbeiter30
WertpapierartOrdinary Share
GeschäftsjahresendeMar 11
Addresse10-2 Tower B, Vertical Business Suite
StadtKUALA LUMPUR
BörseNASDAQ OMX - NASDAQ BASIC
LandMalaysia
Postleitzahl59200
Telefon13072416898
Websitehttps://www.bionexusgenelab.com/
BörsenkürzelBGLC
IPO-datumMar 11, 2020
CEOTan (Lee Su-Leng)

Führungskräfte von BioNexus Gene Lab Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-1.00%
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-1.00%
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Andere
63.04%
Aktionäre
Aktionäre
Anteil
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Andere
63.04%
Aktionärstypen
Aktionäre
Anteil
Corporation
24.00%
Individual Investor
12.39%
Investment Advisor
0.62%
Investment Advisor/Hedge Fund
0.10%
Andere
62.89%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
14
22.28K
1.52%
--
2025Q3
14
22.28K
2.00%
+12.71K
2025Q2
13
9.56K
1.47%
-6.24K
2025Q1
13
15.80K
1.33%
-8.09K
2024Q4
12
17.81K
1.26%
+4.78K
2024Q3
9
13.03K
0.67%
+6.46K
2024Q2
7
6.57K
0.88%
-3.53K
2024Q1
7
10.10K
0.59%
-313.00
2023Q4
6
10.42K
1.15%
-9.94K
2023Q3
5
20.36K
0.00%
+20.36K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelion Diagnostics Pte Ltd
392.33K
16.6%
+392.33K
--
Nov 28, 2025
ARC Group Ltd
175.00K
7.4%
+175.00K
--
Nov 28, 2025
Liew (Choong-Chin)
166.67K
7.05%
-1.00
-0.00%
Nov 28, 2025
Lai (Soo Kow(kenny))
125.00K
5.29%
-1.00
-0.00%
Nov 28, 2025
DRW Securities, LLC
14.65K
0.62%
+14.65K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
--
0%
-2.37K
-100.00%
Jun 30, 2025
Low (Jook Yuen)
1.26K
0.05%
-1.00
-0.08%
Nov 28, 2025
Blackstone Alternative Investment Advisors LLC
3.00
0%
--
--
Jun 30, 2025
Scientech Research LLC
--
0%
-1.08K
-100.00%
Mar 31, 2025
XTX Markets LLC
--
0%
-3.28K
-100.00%
Mar 31, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Apr 03, 2025
Merger
10→1
Datum
Ex-Dividendentag
Art
Verhältnis
Apr 03, 2025
Merger
10→1
KeyAI